Plasma triglycerides (neutral fat) may be divided into 1) that portion which is present during the fasting state and 2) that which, after ingestion of fat, is added to and temporarily augments the fasting level of triglycerides.
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The present investigation deals with the relationship of plasma free fatty acids (plasma FFA) to fasting plasma triglycerides (plasma TG) in man. From these observations a quantitative assessment of the amount of plasma FFA converted to plasma TG will be presented. The data also permit calculations which suggest that plasma FFA may be the major source of fasting plasma TG.
METHODS
Two types of studies were carried out in male patients without known abnormalities of fat metabolism.
1. Non-reinjection experiments. After an overnight fast of 15 hours, 9 subjects were given 0.004 to 0.008 mc albumin-bound palmitic acid-i-C1' intravenously either by single injection or by 2-hour constant infusion. Two individuals received 0.00585 mc of albumin-bound oleic acid-i-C1' and another 0.00597 mc of stearic acid-1-C14.
During the day of the study the subjects were permitted no breakfast, a nonfat lunch, and an unrestricted supper. Venous blood samples were drawn at appropriate intervals over a period of 24 hours after administration of fatty acid C1' for determination of neutral fat activity. Two-ml aliquots of plasma were extracted by the method of Dole (1) . Eight ml of the upper phase, representing 1.85 ml of plasma, was transferred to a separate tube. Ten ml of 0.1 N NaOH in 50 per cent ethanol was added, according to the method of Borgstrbm (2) , in order to * This investigation was supported in part by a grant from the Life Insurance Medical Research Fund; by a research grant H-4807; a training grant, HTS-5369, from the National Heart Institute, Public Health Service; a research grant, A-4535-MET, from the National Institutes of Health, Public Health Service; a research grant for July 1960-61, from the North Carolina Heart Association; and by the Regional Center for the Study of Aging, Duke University. remove fatty acids from the upper phase. The upper phase and its contents were then transferred quantitatively to liquid scintillator vials, dried with a stream of warm air from a hair dryer, and redissolved in 5 ml of phosphor solution for counting in a Packard Tri-Carb liquid scintillation spectrometer. Along with plasma glycerides, the extracts contained cholesterol, cholesterol esters and a small amount of phospholipid. These would also be expected to become labeled; therefore, it was necessary to determine the amount of activity in the various plasma lipids present in the extracts at various times after injection of C4-labeled fatty acids. This was done by means of silicic acid chromatography using the method of Hirsch and Ahrens (3) without modification. Plasma palmitic acid-l-C1 activity was measured as previously described (4) .
The experimental plan required a method which would permit easy and reproducible determinations on a large number of samples. The method selected for measuring plasma TG activity described in the preceding paragraph is based on the facts that: 1) the label in the extracts appeared almost exclusively in TG in the early hours of the procedure, and 2) negligible activity was present in cholesterol, cholesterol esters and phospholipid until at least 4 hours had elapsed. Furthermore, although significant activity appeared in phospholipids, only a small fraction of this phospholipid activity was present in the upper phase extracts, and activity in free cholesterol was minimal. The data justifying the method appear below.
Total plasma triglycerides were determined by the method of Van Handel and Zilversmit (5) , plasma FFA by the method of Dole (1) and esters of carboxylic acids by the method of Rapport and Alonzo (6) . Free cholesterol was precipitated as the digitonide and redissolved in methanol for liquid scintillation counting. Samples of expired air were analyzed for C1402 activity by trapping in Hyamine hydroxide according to the method of Fredrickson and Ono (7).
2. Reinjection experiments. In order to establish with greater certainty the validity of using the rate of disappearance of TG label observed during non-reinjection experiments to measure fasting plasma TG turnover rate, a patient, terminally ill with degenerative cerebellar disease, was given 30 /Ac palmitic acid-i-C1' intravenously. Table I ). (The purpose of the constant infusion studies was to simplify the kinetic problem by attempting to produce a situation in which the specific activity of TG influx into plasma was constant. This was later found to be both unnecessary and impractical.)
Thereafter activity declined relatively rapidly at first and then more slowly over the 24 hour period of observation. Initially there was a straight line exponential decline after attainment of peak plasma activity. There was some uncertainty about this in two studies ( Figure 1C ). In all cases there was a departure from linearity beginning, at the earliest, 6 hours after injection of palmitic acid-i-C14. $ Single injection studies.
hour no activity was detected in cholesterol esters, and at 2 hours 1.5 per cent of the total activity was found in this fraction.
B. CO, activity. Figure 3 illustrates the appearance of CO., activity in expired air in relation to palmitic acid and TG activity during a constant infusion experiment and also illustrates the fact that peak expired CO2 labeling occurs before plasma TG peak activity.
C. Phospholipids. Table II shows the amount of activity in phospholipids at various intervals after the beginning of the studies. These determinations were performed on separate samples of plasma by silicic acid chromatography using D. Cholesterol esters. Figure 4 , a representative example performed as a separate study, shows the appearance of label in cholesterol esters. Activity is initially small, but in 24 hours is responsible for a significant portion of the activity of the extracts. This can be ascertained by comparing the amount of cholesterol ester activity in Figure 4 with the residual total activity in Figure 1, A and B.
E. Free cholesterol. Activity in free cholesterol constituted only a fraction of background activity. Figure 1 ).
II. Reinjection experiments
The results of the two reinjection studies are summarized in Table III (11) found that this organ removed intravenously administered radiopalmitate and that activity was found in liver triglycerides and then in plasma triglycerides. In the experiments of Laurell, the specific activity of liver and plasma triglycerides appeared to be the same so that these findings were thought to be compatible with the concept that fasting plasma triglycerides might be entirely derived from liver triglycerides. On the other hand, Stein and Shapiro believed that liver triglycerides mix with a larger triglyceride pool from depots (10).
II. Discussion of results
A. Reinjection experiments. The observations in man made in this study differ from those in the rat in at least two obvious particulars. First, the rate of disappearance in the non-reinjection studies of Laurell is more rapid than that in man. Second, the rate of disappearance in the rat of reinjected fasting triglycerides is much more rapid than in the non-reinjection experiments (11). In our own studies this difference was either not observed or remained in doubt (see Figure 6 and compare K values in Tables II and  III) . However, unpublished observations in this laboratory in dogs resemble those made in the rat by Laurell. From our own reinjection studies we conclude that the rate of disappearance resembled a simple first order decay and that the volume of distribution of the reinjected TG approximated the calculated plasma volume.
B. Non-reinjection experiments. The activity in an extract containing triglycerides, cholesterol esters, free cholesterol and some phospholipids is considered, on the basis of silic acid chromatographic studies, to represent triglyceride activity alone during the ascending portion of the curve and during the initial descending portion of the curve which forms a straight line on the semilogarithmic plot. Furthermore, the straight logarithmic downslope is considered to be representative of the disappearance of a single substance. This would be valid except in the unusual circum (11) . However, in the present investigation, since only plasma levels were measured, it will be necessary to limit the interpretation arbitrarily to events occurring in the plasma pool even though this pool might be only a fraction of a larger TG pool with which TG equilibrates rapidly. The fractional rate of disappearance of TG-C14 calculated from the TG activity curves is interpreted to represent the rate of disappearance of fasting plasma triglycerides in general. It should be stated in this regard that TG molecules in blood are composed of a mixture of fatty acids (13) and are believed to be removed intact by adipose tissue in vitro (14) . Another point in support of the hypothesis that TG is removed intact is the observation in this study that both oleic and palmitic acids, the two most abundant compounds in this class, behaved in the same way and fell into the same range of disappearance rates from plasma. It is also known that lower glycerides do not normally appear in plasma (3). Since TG molecules are composed of a mixture of fatty acids, one would anticipate that lower glycerides would be present in plasma if the rate of disappearance were more rapid for one species of fatty acid than for another. Futhermore, it is assumed that the calculated fractional rate is also the rate of disappearance for TG throughout the course of the study, especially during the time of increasing triglyceride activity.
Another important assumption, relating to the method of interpretation which follows, involves the concept that once peak plasma triglyceride activity has been reached and the straight exponential downward decay begins, no further net addition of TG label into the TG pool takes place. The word "net" is emphasized since a straight line could be observed if plasma TG equilibrates rapidly with other TG pools, i.e., if plasma TG were part of a larger TG pool from which TG disappearance proceeded at a uniform rate. The question that this investigation attempts to answer does not concern the total magnitude of conversion of FFA to TGFA, but whether enough FFA becomes TGFA to account for the observed TG concentration in plasma. The concept of "no further net addition" is justified by the following arguments. First, further net entry of label would alter linearity. Second, a model which fits the observed data was based on the observed rate of TG decay and a rate of entry into plasma also approximated from the data. The following equation was derived:
k2-ki where x is plasma TG activity, ki is the rate of disappearance from the pool emptying into plasma, k2 is the plasma TG fractional disappearance rate, and zo is the amount of TG label released or equilibrating into plasma (15) . Plotting this equation with values approximating those obtained experimentally gives a curve resembling the experimental curves. This equation, furthermore, is based on the assumption that release of TG label into plasma is exponential with time, an assumption which is consistent with the form of the increasing limb of the triglyceride activity curves. Third, inspection of the curves indicates that label equilibrates very rapidly at first and that this rapid rate of entry slows promptly and, therefore, the net influx of label would be expected to become rapidly insignificant and approach zero. The consequence of this would be that only the rate of disappearance of label would be manifest and that this picture would be uncomplicated by further addition of labeled material.
In addition to the foregoing, two other facts are pertinent to the discussion. First, plasma FFA is composed of about 50 per cent oleic acid, 30 (8) .
The presentation which follows is not intended to represent an accurate description of the kinetics of the individual studies but serves to indicate in a general way the magnitude of the conversion of FFA to plasma TG and to suggest that plasma FFA are the major source of plasma TG. The fractional disappearance rate and volume of distribution of plasma FFA, the plasma volume, and the values derived from these quantities were not experimentally determined but are representative of known normal values and may be the source of considerable error in individual studies. The interpretation is presented below.
In order to take into account the likely situation that plasma TG may be in part of a larger TG pool probably including liver TG, it is necessary to interpret the data in a manner which is independent of pool size. The following model is pictured. FFA label is converted to TGFA label which then equilibrates rapidly with all parts of the TG pool including plasma. This pool may be the same size or larger than the plasma pool. Disappearance then proceeds at a uniform rate from the entire pool.
In Figure 7 , the logarithm of plasma TG activity, x, is plotted against time, t. Let z = total TGFA activity (TGFA*) which has equilibrated with the plasma compartment, i.e., the total amount of administered fatty acid label (FA*), which appeared in plasma as TGFA*. Let y = amount of TGFA* which has left plasma from time t = 0 to t = ti; t1 is any point in time on the straight downlimb of the semilogarithmic plot.
Let M = amount of FA label administered. Let F = fraction of FA label converted to plasma TGFA*. F equals z AM. Let a = endogenous FFA turnover rate or flux. Let k = fractional disappearance rate of plasma TG. Then at any time t, on the straight downlimb of the semilogarithmic plot, z = x -y; dy, the amount of TGFA* which has left plasma during an interval of time, dt, = kx dt, and the total amount of TFGA*, y, which has left the rti plasma from t = 0 to t = t = f kxdt tj~~~~~t and z = x -k x dt.
The amount of TGFA formed per hour which enters plasma equals the fraction of FA label converted to plasma TGFA* times the endogenous FFA turnover rate. This equals Fa, which
If TGFA enters plasma at the rate of Fa milliinoles per hour and leaves at the fractional disappearance rate k, the anticipated plasma TGFA content which will be reached can be expressed by Fa/k (1 -ekt) (17) .
When I= x, plasma TFGA content will equal Eu,/k; or, substituting In calculating the data with the equations presented, the following factors were taken into account: 1) Plasma volumes were calculated on the basis of 40 ml plasma per kg body weight (18) .
2) It was assumed that the fraction of palmitic acid-i-C14 converted to TGFA* is representative 2 Since the writing of this paper an alternative method of analyzing the data has been proposed. The derivation which follows is more general in nature, and under certain circumstances requires no knowledge concerning the rate of disappearance of TGFA.
Let w = time of introduction of labeled FA. Let M = total dose of labeled FA. Let f (t -) = fraction of a given quantity of FFA which enters plasma at time and which is to be found with plasma TGFA pool at time t (a steady state is assumed). Let m (w) = plasma FFA flux (rate of entry of FFA into plasma). Then, the quantity of FFA which entered plasma during time interval dw is m(w)dco. At time t from the time this quantity, m(co)dco, entered, the quantityf(t -w)m(co)dw would be found in the plasma TGFA pool, or adding up for all previous time intervals we obtain: total plasma TGFA = ff(t -)m(w)dw
The substitution Q = t-co transforms this into the equivalent expression:
If the rate of entry of FFA into the plasma is constant, say m(w) = a, then the quantity of TGFA present at time t will be: of fatty acids as a whole. Whereas this is not strictly true it is a very reasonable approximation, since the fatty acid composition of plasma FFA and plasma TGFA is almost identical (8, 16) and since oleic and palmitic acids behaved similarly. 3) Endogenous hourly FFA turnover rate, a, was estimated from the average plasma FFA level during the period of TGFA* formation by using a fractional disappearance rate of 0.3 per minute (9) . The plasma volume was taken as the volume of distribution of FFA, although the latter volume may be somewhat greater than the former (4, 9 (14) . A point which should be emphasized is that the results, suggesting that plasma FFA conversion to plasma TGFA is sufficient to account for plasma TG concentration, would be the same if these calculations were based on a unit volume of plasma; i.e., the interpretation is independent of pool size. Furthermore, the value obtained for the fraction of radiopalmitate converted to plasma TGFA applies only to the initial equilibration of label into plasma. The actual fraction of FFA converted to TGFA might be considerably in excess of this amount if one considers, as Laurell claims (11), that plasma TG specific activity might well be the same as that in liver and that liver TG probably greatly exceeds plasma TG.
DISCUSSION AND CONCLUSIONS
An important concomitant of the present interpretation is the concept that one of the factors relating directly to the plasma TG level is the magnitude of plasma FFA turnover rate. This idea finds support in observations relating plasma FFA concentration to plasma TG concentration. For example, Havel (19) found that administration of glucose, which causes a fall in plasma FFA, also causes a fall in plasma TG concentration. Dury and Treadwell (20) showed that epinephrine which raises plasma FFA concentration also raises plasma TG concentration. Both diabetes and starvation produce a rise in plasma FFA and plasma TG.
Another point which should be made is that the present study does not distinguish actual triglyceride formation from a process which exchanges one TGFA for another from FFA. There is, however, suggestive evidence from the studies of others that FFA may not be released from the liver. The large positive FFA arteriovenous difference of the blood perfusing liver (21) suggests that such an exchange may not be the only mechanism concerned. Stein and Shapiro were unable to find significant amounts of FFA label after uptake of C14-triglycerides by rat liver (22) . This last point is, however, difficult to evaluate because liver FFA is rapidly diluted by a large FFA flux from plasma. It has also been shown that plasma triglycerides are removed by adipose tissue in vitro (14, 23) , and that only a fraction of administered ,8-lipoprotein triglyceride is taken up by liver (22) .
If plasma triglyceride undergoes a fate other than recirculation to liver and if, as has been shown in these isotopic studies, the majority, and perhaps all plasma TG originates from liver, it would be unlikely that incorporation of FFA into TGFA would be entirely an exchange phenomenon. However, proof of this contention is not possible at present.
It is also necessary to point out evidence concerning the importance of the liver in the incorporation of FFA into TGFA and the lack of participation of extrahepatic tissues in contributing to the fasting triglyceride via an FFA precursor. Such evidence is forthcoming not only from animal studies already mentioned but also from the recent observation by Havel and Goldfien (24) that hepatectomy in dogs abolished the conversion of FFA to TGFA.
It is concluded from the data presented and from the interpretation of these data that plasma FFA is a major source of fasting plasma triglyceride. The calculations, furthermore, strongly suggest that FFA is involved in a process in which all three fatty acids of triglyceride turn over and that FFA is therefore the preponderant source of fasting TGFA.
SUM MARY
Observations have been made on the incorporation of injected C14-labeled fatty acids into triglycerides, cholesterol esters, free cholesterol and phospholipids.
An estimate was made of the quantitative aspect of the formation of triglyceride label. The results of this estimate are consistent with the hypothesis that a major fraction of fasting plasma triglyceride is derived from plasma fatty acids.
